HomeMarket NewsRBI’s New collateral rule is a ‘death knell’ for prop trading, warns Crosseas Capital MD
Rajesh Baheti, Managing Director of Crosseas Capital Services, estimated that Indian broking houses and domestic high-frequency trading (HFT) firms account for 30% to 35% of total exchange turnover. He said the new collateral requirements could reduce activity in this segment by 30% to 35%, resulting in an estimated 10% to 12% decline in overall daily trading volumes.

The Reserve Bank of India’s new rules for proprietary trading, which came into effect on July 1, are expected to significantly increase funding costs for domestic broking firms and high-frequency traders, according to Rajesh Baheti, Managing Director of Crosseas Capital Services.
Baheti said, “It’s the most significant death knell to the prop trading industry since the NSE came into existence.”
Under the revised framework, guarantees used for proprietary trades
must now be fully collateralised, with at least 50% of the collateral maintained in cash or fixed deposits. Earlier, brokers could obtain bank guarantees while locking up much less cash, allowing them to operate with higher leverage.
Baheti believes the new framework will make proprietary trading less efficient by increasing the amount of capital that firms must set aside for trading activities.
“If the return on equity goes below a certain threshold, the whole business becomes unviable, considering the risk,” he said.
A central part of Baheti’s argument is that the rule falls unevenly on Indian firms. Foreign trading firms and foreign high-frequency traders, he said, can secure funding directly from banks overseas, where the RBI has no jurisdiction. “They will continue to thrive at the cost of Indian firms,” he said. “We are exporting our income that will be converted into dollars and taken out of the country.”
Asked whether non-bank lenders could step in to fill the funding gap, Baheti said that’s not a workaround. Clearing corporations — the entities that guarantee trades on India’s exchanges — don’t accept bank guarantees issued by non-banking financial companies, he said, so any bank-guarantee-based funding has to come from a bank.
According to Baheti, Indian broking houses and Indian HFTs together account for 30% to 35% of exchange turnover, and that the new collateral rule could reduce that segment’s activity by a similar 30% to 35% — translating to roughly a 10% to 12% hit to overall daily volumes.
He also argued that the changes could create an uneven playing field between Indian and overseas firms. While domestic brokers will have to comply with the stricter collateral requirements, foreign trading firms may continue to access funding through overseas banking channels, where financing terms could remain more favourable.
Baheti questioned the rationale behind the RBI’s decision, “There’s no credit risk. There are no NPAs in the system,” he said while questioning the need for the new restrictions.
Dhiraj Relli, Managing Director and CEO of HDFC Securities, believes the transition will be more gradual than many expect. He noted that the new 100% collateral requirement will apply only when existing bank guarantees are renewed, reducing the likelihood of an immediate disruption to trading activity.
However, not everyone in the industry shares Baheti’s concerns. HDFC Securities Managing Director & CEO Dhiraj Relli has said the impact is likely to be more gradual, as the new collateral requirement will apply when existing bank guarantees are renewed.
He also believes brokers still have alternative funding options, while NeoStrat Advisors Founder Abizer Diwanji has argued that the RBI’s move is a deliberate step to curb excessive leverage in the market.
For the entire discussion, watch the accompanying video
First Published:
Jul 1, 2026 9:29 AM
IST
Note To Readers
Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.